Key facts
- Gennate’s last known valuation is $1.5M (Aug 2025).
- It has raised $1.3M; the latest was Seed Round ($940K) in Mar 2026.
- Notable investors include SFC Capital, Greater Manchester Combined Authority, BIC Euronova, Salonica Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Gennate
- ·The full record, as it builds
Funding rounds
No funding rounds for Gennate are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gennate
Developer of nanotechnology materials designed to enhance agricultural productivity and sustainability. The company utilizes proprietary nanofabrication technology to produce micronutrient formulations for various plant types and farming methods, including seed treatment, vertical farming, and general cultivation, enabling agricultural producers to improve nutrient absorption, increase yield efficiency, reduce chemical dependency, and support environmentally responsible farming practices.
- Sector
- Materials and Resources
- HQ
- London, United Kingdom
- Founded
- 2022
- Employees
- 2
- Website
- gennate.com/
- Ownership
- Privately Held (backing)
Gennate doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gennate shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gennate in its N-PORT filings yet. We sweep new filings monthly.